Doxil® — The first FDA-approved nano-drug: Lessons learned

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,771 · see citing works

Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,784 · see citing works

PEGylation, successful approach to drug delivery

Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,344 · see citing works

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030 · see citing works

Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness

Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689 · see citing works

Pharmacokinetics of Pegylated Liposomal Doxorubicin

Gabizón, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,639 · see citing works

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.

Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382 · see citing works

Transport of molecules in the tumor interstitium: a review.

Jain, R. K. (1987) · PubMed · Cited by 1,357 · see citing works

Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.

Abuchowski, A., McCoy, J. R., Palczuk, N. C., Es, T. V., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,276 · see citing works

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

Gordon, A. N., Fleagle, J., Guthrie, D., Parkin, D. E., Gore, M. E., & Lacave, Á. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3312 · Cited by 1,212 · see citing works

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

Maeda, H., Bharate, G. Y., & Daruwalla, J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,171 · see citing works

Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Gabizón, A., & Papahadjopoulos, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6949 · Cited by 1,134 · see citing works

Adriamycin

Blum, R. H., & CARTER, S. K. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-2-249 · Cited by 1,059 · see citing works

Transport and Diffusion Across Cell Membranes

Stein, W. D., & Lieb, W. R. (1986) · Elsevier eBooks · doi:10.1016/b978-0-12-664660-3.x5001-7 · Cited by 1,029 · see citing works

Sterically stabilized liposomes

Woodle, M. C., & Lasiç, D. D. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90038-c · Cited by 1,018 · see citing works

Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.

Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934 · see citing works

Transport of molecules across tumor vasculature

Jain, R. K. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00047468 · Cited by 869 · see citing works

Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

McKelvey, E. M., Gottlieb, J. A., Wilson, H. E., Haut, A., Talley, R. W., Stephens, R. L., Lane, M., Gamble, J. F., Jones, S. E., Grozea, P. N., et al. (1976) · Cancer · doi:10.1002/1097-0142(197610)38:4 · Cited by 819 · see citing works

A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.

Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000) · PubMed · Cited by 746 · see citing works

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733 · see citing works

Polymeric biomaterials

Griffith, L. G. (2000) · Acta Materialia · doi:10.1016/s1359-6454(99)00299-2 · Cited by 733 · see citing works

Large unilamellar liposomes with low uptake into the reticuloendothelial system

Allen, T. M., & Chonn, A. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80506-9 · Cited by 729 · see citing works

Liposomes for the sustained drug release in vivo

Blume, G., & Cevc, G. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90440-y · Cited by 701 · see citing works

Liposome application: problems and prospects.

Barenholz, Y. (2001) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00090-x · Cited by 659 · see citing works

Liposomes as drug carriers

Fendler, J. H., & Romero, A. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90481-7 · Cited by 656 · see citing works

Effect of Vascular Normalization by Antiangiogenic Therapy on Interstitial Hypertension, Peritumor Edema, and Lymphatic Metastasis: Insights from a Mathematical Model

Jain, R. K., Tong, R. T., & Munn, L. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4102 · Cited by 612 · see citing works

The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors

Needham, D., & Dewhirst, M. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00233-2 · Cited by 572 · see citing works

The anthracyclines: will we ever find a better doxorubicin?

Weiss, R. B. (1992) · PubMed · Cited by 558 · see citing works

Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes

Schroeder, A., Kost, J., & Barenholz, Y. (2009) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2009.08.003 · Cited by 484 · see citing works

Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention

Szebeni, J., Muggia, F. M., Gabizón, A., & Barenholz, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.017 · Cited by 424 · see citing works

The use of differential scanning calorimetry as a tool to characterize liposome preparations

Biltonen, R. L., & Lichtenberg, D. A. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90062-8 · Cited by 414 · see citing works

Liposomes: From Biophysics to Therapeutics

Martin, F. J. (1989) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600780223 · Cited by 354 · see citing works

Cancer Management: A Multidisciplinary Approach

Pazdur, R., Coia, L. R., Hoskins, W. J., & Wagman, L. D. (2007) · Cited by 354 · see citing works

Liposome drugs' loading efficiency: A working model based on loading conditions and drug's physicochemical properties

Zucker, D., Marcus, D., Barenholz, Y., & Goldblum, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.036 · Cited by 340 · see citing works

Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer

Garbuzenko, O. B., Barenholz, Y., & Priev, A. (2005) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2005.02.003 · Cited by 319 · see citing works

Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.

Poste, G. H., Bucana, C. D., Raz, A., Bugelski, P. J., Kirsh, R. L., & Fidler, I. J. (1982) · PubMed · Cited by 309 · see citing works

Ultrasound triggered release of cisplatin from liposomes in murine tumors

Schroeder, A., Honen, R., Turjeman, K., Gabizón, A., Kost, J., & Barenholz, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.007 · Cited by 305 · see citing works

Hydration of Polyethylene Glycol-Grafted Liposomes

Tirosh, O., Barenholz, Y., Katzhendler, J., & Priev, A. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77849-x · Cited by 299 · see citing works

Liposomes: Preparation, Characterization, and Preservation

Lichtenberg, D. A., & Barenholz, Y. (1988) · Methods of biochemical analysis · doi:10.1002/9780470110546.ch7 · Cited by 291 · see citing works

The response of fluorescent amines to pH gradients across liposome membranes

Deamer, D. W., Prince, R. C., & Crofts, A. R. (1972) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(72)90180-0 · Cited by 266 · see citing works

Gelation of liposome interior A novel method for drug encapsulation

Lasiç, D. D., Frederik, P. M., Stuart, M. C. A., Barenholz, Y., & McIntosh, T. J. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80947-f · Cited by 261 · see citing works

Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.

Schroeder, A., Avnir, Y., Weisman, S., Najajreh, Y., Gabizon, A., Talmon, Y., Kost, J., & Barenholz, Y. (2007) · Langmuir · doi:10.1021/la0631668 · Cited by 239 · see citing works

Prolongation of the Circulation Time of Doxorubicin Encapsulated in Liposomes Containing a Polyethylene Glycol-Derivatized Phospholipid: Pharmacokinetic Studies in Rodents and Dogs

Gabizón, A., Barenholz, Y., & Bialer, M. (1993) · Pharmaceutical Research · doi:10.1023/a:1018907715905 · Cited by 238 · see citing works

Introduction and overview of peptide and protein pegylation

Veronese, F. M., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 235 · see citing works

Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome

Szebeni, J., Bedöcs, P., Rozsnyay, Z., Weiszhár, Z., Urbanics, R., Rosivall, L., Cohen, R., Garbuzenko, O. B., Báthori, G., Tóth, M., et al. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.06.003 · Cited by 220 · see citing works

Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes

Symon, Z., PEYSER, A. B., Tzemach, D., Lyass, O., Sucher, E., Shezen, E., & Gabizón, A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990701)86:1 · Cited by 214 · see citing works

Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery.

Lasic, D. D., Čeh, B., Stuart, M. C. A., Guo, L., Frederik, P. M., & Barenholz, Y. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00159-z · Cited by 209 · see citing works

Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes.

Bolotin, E. M., Cohen, R., Bar, L. K., Emanuel, N., Ninio, S., Barenholz, Y., & Lasiç, D. D. (1994) · Journal of Liposome Research · doi:10.3109/08982109409037057 · Cited by 207 · see citing works

Clinical Pharmacology of Liposomal Anthracyclines: Focus on Pegylated Liposomal Doxorubicin

Solomon, R. O., & Gabizón, A. (2008) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2008.n.001 · Cited by 200 · see citing works

Animal Models of Complement-Mediated Hypersensitivity Reactions to Liposomes and Other Lipid-Based Nanoparticles

Szebeni, J., Alving, C. R., Rosivall, L., Bünger, R., Baranyi, L., Bedöcs, P., Tóth, M., & Barenholz, Y. (2007) · Journal of Liposome Research · doi:10.1080/08982100701375118 · Cited by 199 · see citing works

A Novel Liposomal Bupivacaine Formulation to Produce Ultralong-Acting Analgesia

Grant, G. J., Barenholz, Y., Bolotin, E. M., Bansinath, M., Turndorf, H., Piskoun, B., & Davidson, E. M. (2004) · Anesthesiology · doi:10.1097/00000542-200407000-00021 · Cited by 170 · see citing works

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Zamboni, W. C., Gervais, A. C., Egorin, M. J., Schellens, J. H. M., Zuhowski, E. G., Pluim, D., Joseph, E., Hamburger, D. R., Working, P. K., Colbern, G. T., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0719-4 · Cited by 166 · see citing works

Liposomes in the therapy of infectious diseases and cancer

Borek, F. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90331-o · Cited by 165 · see citing works

Liposomal protection of adriamycin-induced cardiotoxicity in mice.

Rahman, A., Kessler, A., More, N., Sikic, B. I., Rowden, G., Woolley, P. V., & Schein, P. S. (1980) · PubMed · Cited by 160 · see citing works

A New Look at Lipid-Membrane Structure in Relation to Drug Research

Mouritsen, O. G., & Jørgensen, K. (1998) · Pharmaceutical Research · doi:10.1023/a:1011986613392 · Cited by 159 · see citing works

Enzymatic Hydrolysis of Sphingolipids

Barnholz, Y., Roitman, A., & Gátt, S. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99833-9 · Cited by 159 · see citing works

Handbook of cancer chemotherapy

(1993) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(93)90321-b · Cited by 158 · see citing works

Relevancy of Drug Loading to Liposomal Formulation Therapeutic Efficacy

Barenholz, Y. (2003) · Journal of Liposome Research · doi:10.1081/lpr-120017482 · Cited by 157 · see citing works

Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).

Working, P. K., & Dayan, A. D. (1996) · PubMed · Cited by 156 · see citing works

Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin

Gabizón, A., Chisin, R., Amselem, S., Druckmann, S., Cohen, R., Goren, D., Fromer, I. R., Peretz, T., Sulkes, A., & Barenholz, Y. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.476 · Cited by 144 · see citing works

Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation

Woodle, M. C. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90069-f · Cited by 140 · see citing works

In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release

Horowitz, A. T., Barenholz, Y., & Gabizón, A. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90084-y · Cited by 139 · see citing works

Liposomes: Rational Design

Chisti, Y. (1999) · Biotechnology Advances · doi:10.1016/s0734-9750(99)00009-9 · Cited by 135 · see citing works

Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

Rahman, A., Carmichael, D. C., Harris, M. H., & Roh, J. K. (1986) · PubMed · Cited by 133 · see citing works

Enzymes of Complex Lipid Metabolism

Gatt, S., & Barenholz, Y. (1973) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.42.070173.000425 · Cited by 132 · see citing works

The Cardiotoxicology of Anthracycline Chemotherapeutics: TRANSLATING MOLECULAR MECHANISM INTO PREVENTATIVE MEDICINE

Peng, X. (2005) · Molecular Interventions · doi:10.1124/mi.5.3.6 · Cited by 131 · see citing works

Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study

Gabizón, A., Peretz, T., Sulkes, A., Amselem, S., Ben‐Yosef, R., Ben-Baruch, N. E., Catane, R., Biran, S., & Barenholz, Y. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90350-7 · Cited by 130 · see citing works

Catecholamine uptake and concentration by liposomes maintaining pH gradients

Nichols, J. L., & Deamer, D. W. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90169-3 · Cited by 130 · see citing works

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

Terwogt, J. M. M., Groenewegen, G., Pluim, D., Maliepaard, M., Tibben, M. M., Huisman, A., Huinink, W. W. T. B., Schot, M. E., Welbank, H., Voest, E. E., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100371 · Cited by 124 · see citing works

Handbook of cancer chemotherapy

Griffiths, M. (1996) · European Journal of Cancer Part B Oral Oncology · doi:10.1016/s0964-1955(96)90004-4 · Cited by 121 · see citing works

Optimization and Upscaling of Doxorubicin-Containing Liposomes for Clinical Use

Amselem, S., Barenholz, Y., & Gabizon, A. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600791202 · Cited by 115 · see citing works

Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)

Alberts, D. S., Liu, P. Y., Wilczynski, S. P., Clouser, M. C., López, A. M., Michelin, D. P., Lanzotti, V. J., & Markman, M. M. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.075 · Cited by 115 · see citing works

Comparative Long-Term Study of the Toxicities of Free and Liposome-Associated Doxorubicin in Mice After Intravenous Administration 2

Gabizon, A., Meshorer, A., & Barenholz, Y. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/77.2.459 · Cited by 114 · see citing works

A Quantitative Model for Using Acridine Orange as a Transmembrane pH Gradient Probe

Clerc, S., & Barenholz, Y. (1998) · Analytical Biochemistry · doi:10.1006/abio.1998.2639 · Cited by 111 · see citing works

Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.

Gabizón, A., Goren, D., FUKS, Z. Y., Barenholz, Y., Dagan, A., & Meshorer, A. (1983) · PubMed · Cited by 111 · see citing works

Principles of Oncologic Pharmacotherapy

Takimoto, C. H. M., & Calvo, E. (2005) · Cited by 110 · see citing works

Direct comparison of two pegylated liposomal doxorubicin formulations: Is AUC predictive for toxicity and efficacy?

Cui, J., Li, C., Guo, W., Li, Y., Wang, C., Zhang, L., Zhang, L., Hao, Y., & Wang, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.002 · Cited by 109 · see citing works

In Vitro and In Vivo Characterizations of Pegylated Liposomal Doxorubicin

Jiang, W., Lionberger, R. A., & Yu, L. X. (2011) · Bioanalysis · doi:10.4155/bio.10.204 · Cited by 101 · see citing works

Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.

Rahman, A., White, G. H., More, N., & Schein, P. S. (1985) · PubMed · Cited by 100 · see citing works

Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model

Gabizón, A., Goren, D., FUKS, Z. Y., Meshorer, A., & Barenholz, Y. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.103 · Cited by 94 · see citing works

Quantitative structure - property relationship modeling of remote liposome loading of drugs

Cern, A., Golbraikh, A., Sedykh, A., Tropsha, A., Barenholz, Y., & Goldblum, A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.029 · Cited by 93 · see citing works

Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines

Ulmansky, R., Turjeman, K., Baru, M., Katzavian, G., Harel, M., Sigal, A., Naparstek, Y., & Barenholz, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.024 · Cited by 88 · see citing works

Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.

Andrews, P. A., Brenner, D. E., Chou, F. T., Kubo, H., & Bachur, N. R. (1980) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)00245-4 · Cited by 87 · see citing works

Stability of liposomal doxorubicin formulations: Problems and prospects

Barenholz, Y., Amselem, S., Goren, D., Cohen, R., Gelvan, D., Samuni, A., Golden, E. B., & Gabizón, A. (1993) · Medicinal Research Reviews · doi:10.1002/med.2610130404 · Cited by 86 · see citing works

Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy

Zucker, D., Andriyanov, A. V., Steiner, A., Raviv, U., & Barenholz, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.003 · Cited by 84 · see citing works

Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers.

Garbuzenko, O., Zalipsky, S., Qazen, M., & Barenholz, Y. (2005) · Langmuir · doi:10.1021/la0479105 · Cited by 84 · see citing works

Sterically stabilized liposomes in cancer therapy and gene delivery.

Lasiç, D. D., Jj, V., & Working, P. K. (1999) · PubMed · Cited by 81 · see citing works

Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance

Peleg‐Shulman, T., Gibson, D., Cohen, R., Abra, R. M., & Barenholz, Y. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00359-x · Cited by 80 · see citing works

Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: Implications for pharmacokinetic studies

Druckmann, S., Gabizón, A., & Barenholz, Y. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90329-5 · Cited by 77 · see citing works

Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes.

Zucker, D., & Barenholz, Y. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.024 · Cited by 77 · see citing works

DRV Liposomal Bupivacaine: Preparation, Characterization, and In Vivo Evaluation in Mice

Grant, G. J., Barenholz, Y., Piskoun, B., Bansinath, M., Turndorf, H., & Bolotin, E. M. (2001) · Pharmaceutical Research · doi:10.1023/a:1011059131348 · Cited by 76 · see citing works

Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial

Joly, F., Ray-Coquard, I. L., Fabbro, M., Donoghoe, M. W., Boman, K., Sugimoto, A. K., Vaughan, M. M., Reinthaller, A., Vergote, I. B., Ferrandina, G., et al. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.04.019 · Cited by 71 · see citing works

A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin

Veal, G. J., Griffin, M. J., Price, E., Parry, A., Dick, G., Little, M., Yule, S. M., Morland, B. J., Estlin, E., Hale, J., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1723 · Cited by 69 · see citing works

THE NEXT GENERATION OF LIPOSOME DELIVERY SYSTEMS: RECENT EXPERIENCE WITH TUMOR-TARGETED, STERICALLY-STABILIZED IMMUNOLIPOSOMES AND ACTIVE-LOADING GRADIENTS

Abra, R. M., Bankert, R. B., Chen, F., Egilmez, N. K., Huang, K., Saville, R., Slater, J. L., Sugano, M., & Yokota, S. J. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004770 · Cited by 69 · see citing works

Targeted Delivery of Doxorubicin via Sterically Stabilized Immunoliposomes: Pharmacokinetics and Biodistribution in Tumor-bearing Mice

Emanuel, N., Kedar, E., Bolotin, E. M., Smorodinsky, N. I., & Barenholz, Y. (1996) · Pharmaceutical Research · doi:10.1023/a:1016096910822 · Cited by 64 · see citing works

The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior

Goren, D., Gabizón, A., & Barenholz, Y. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90165-k · Cited by 63 · see citing works

Liposome Technology

(2010) · CRC Press eBooks · doi:10.1201/9780849397264 · Cited by 61 · see citing works

Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes

Rahman, A., Fumagalli, A., Barbieri, B., Schein, P., & Casazza, A. (1986) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00255281 · Cited by 58 · see citing works

Delivery of Cytokines by Liposomes. I. Preparation and Characterization of Interleukin-2 Encapsulated in Long-Circulating Sterically Stabilized Liposomes

Kedar, E., Rutkowski, Y., Braun, E., Emanuel, N., & Barenholz, Y. (1994) · Journal of Immunotherapy · doi:10.1097/00002371-199407000-00005 · Cited by 58 · see citing works

Prolonged analgesia from Bupisome and Bupigel formulations: From design and fabrication to improved stability

Cohen, R., Kanaan, H., Grant, G. J., & Barenholz, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.030 · Cited by 57 · see citing works

Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trial

Gundersen, S., Kvinnsland, S., Klepp, O., Kvaløy, S., Lund, E., & Høst, H. (1986) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(86)90075-1 · Cited by 56 · see citing works

Reduced UV-Induced Degradation of Doxorubicin Encapsulated in Polyethyleneglycol-Coated Liposomes

Bandak, S., Ramu, A., Barenholz, Y., & Gabizon, A. (1999) · Pharmaceutical Research · doi:10.1023/a:1018869818282 · Cited by 53 · see citing works

Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?

Mamidi, R. N. V. S., WENG, S., Stellar, S., Wang, C., Yu, N. Y., Huang, T. J., Tonelli, A. P., Kelley, M. F., Angiuoli, A., & Fung, M. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1406-x · Cited by 52 · see citing works

Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2.

Cabanes, A., Even‐Chen, S., Zimberoff, J., Barenholz, Y., Kedar, E., & Gabizón, A. (1999) · PubMed · Cited by 52 · see citing works

Enzymatic Assays for Quality Control and Pharmacokinetics of Liposome Formulations: Comparison with Nonenzymatic Conventional Methodologies

Shmeeda, H., Even‐Chen, S., Honen, R., Cohen, R., Weintraub, C., & Barenholz, Y. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)67017-5 · Cited by 47 · see citing works

Targeting of drugs with synthetic systems

Peppas, N. A. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90044-7 · Cited by 44 · see citing works

Preparation and Characterization of Doxorubicin-Loaded Sterically Stabilized Immunoliposomes

Emanuel, N., Kedar, E., Bolotin, E. M., Smorodinsky, N. I., & Barenholz, Y. (1996) · Pharmaceutical Research · doi:10.1023/a:1016028106337 · Cited by 43 · see citing works

In vitro tests to predict in vivo performance of liposomal dosage forms

Amselem, S., Cohen, R., & Barenholz, Y. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90067-d · Cited by 42 · see citing works

Delivery of Cytokines by Liposomes. II. Interleukin-2 Encapsulated in Long-Circulating Sterically Stabilized Liposomes

Kedar, E., Braun, E., Rutkowski, Y., Emanuel, N., & Barenholz, Y. (1994) · Journal of Immunotherapy · doi:10.1097/00002371-199408000-00005 · Cited by 39 · see citing works

Hydrolysis of sphingomyelin liposomes by sphingomyelinase

Gátt, S., Herzl, A., & Barenholz, Y. (1973) · FEBS Letters · doi:10.1016/0014-5793(73)80670-2 · Cited by 37 · see citing works

Incorporation of amphotericin B into large unilamellar vesicles composed of phosphatidylcholine and phosphatidylglycerol

Madden, T. D., Janoff, A. S., & Cullis, P. R. (1990) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(90)90114-7 · Cited by 30 · see citing works

Amphipathic Weak Base Loading into Preformed Liposomes Having a Transmembrane Ammonium Ion Gradient: From the Bench to Approved Doxil

Barenholz, Y. (2016) · CRC Press eBooks · doi:10.1201/9780849397271-5 · Cited by 30 · see citing works

Doxil® — The First FDA-Approved Nano-Drug: From an Idea to a Product

Barenholz, Y. (2020) · doi:10.1201/9781003125259-16 · Cited by 30 · see citing works

Oxidative stress effect on the integrity of lipid bilayers is modulated by cholesterol level of bilayers

Tirosh, O., Kohen, R., Katzhendler, J., Alon, A., & Barenholz, Y. (1997) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(97)00019-4 · Cited by 29 · see citing works

Rational design of amphiphile-based drug carriers and sterically stabilized carriers

Barenholz, Y., & Cohen, R. (1995) · Journal of Liposome Research · doi:10.3109/08982109509012690 · Cited by 28 · see citing works

Liposomes in Drug Delivery

Zhang, B. (2001) · CRC Press eBooks · doi:10.1201/9780203904671-31 · Cited by 28 · see citing works

The Antioxidant Tempamine: In Vitro Antitumor and Neuroprotective Effects and Optimization of Liposomal Encapsulation and Release

Wasserman, V., Kizelsztein, P., Garbuzenko, O. B., Kohen, R., Ovadia, H., Tabakman, R., & Barenholz, Y. (2007) · Langmuir · doi:10.1021/la060218k · Cited by 25 · see citing works

Complement Activation, Immunogenicity, and Immune Suppression as Potential Side Effects of Liposomes

Szebeni, J., & Barenholz, Y. (2020) · doi:10.1201/9781003125259-12 · Cited by 23 · see citing works

Stability of anthracycline antitumour agents in infusion fluids.

Beijnen, J. H., Rosing, H., Pa, D. V., & UNDERBERG, W. J. M. (1985) · PubMed · Cited by 19 · see citing works

Investigations on the antitumor efficacy of liposome-associated doxorubicin in murine tumor models.

Gabizón, A., Goren, D., & Barenholz, Y. (1989) · PubMed · Cited by 18 · see citing works

Novel synthetic phospholipid protects lipid bilayers against oxidation damage: role of hydration layer and bound water

Tirosh, O., Kohen, R., Katzhendler, J., Gorodetsky, R., & Barenholz, Y. (1997) · Journal of the Chemical Society Perkin Transactions 2 · doi:10.1039/a601955b · Cited by 17 · see citing works

Changes of Vascular Pattern of Tumors and Surrounding Tissue During Different Phases of Metastatic Growth

Bassermann, R. (1986) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-82635-1_32 · Cited by 15 · see citing works

Qualitative aspects of the degradation of mitomycins in alkaline solution

Beijnen, J. H., den Hartigh, J., & Underberg, W. J. M. (1985) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(85)80008-x · Cited by 15 · see citing works

Amphipathic Weak Base Loading into Preformed Liposomes Having a Transmembrane Ammonium Ion Gradient: From the Bench to Approved Doxil

(2018) · CRC Press eBooks · doi:10.1201/9781420005875-27 · Cited by 12 · see citing works

Design, Characterization and Anti-Tumor Activity of Adriamycin-Containing Phospholipid Vesicles

Gabizón, A., Goren, D., Ramu, A., & Barenholz, Y. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5185-6_17 · Cited by 9 · see citing works

Liposomes in Drug Delivery

Zhang, Y., eh, B. C., & Lasiç, D. D. (2001) · CRC Press eBooks · doi:10.1201/9780203904671.ch29 · Cited by 6 · see citing works

From fusion to magic bullets: The influence of dimitri papahadjopoulos

Allen, T. M. (1995) · Journal of Liposome Research · doi:10.3109/08982109509012671 · Cited by 2 · see citing works

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · see citing works

Nano based drug delivery systems: recent developments and future prospects

Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodríguez-Torres, M. D. P., Acosta‐Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,720 · see citing works

Cancer nanomedicine: progress, challenges and opportunities

Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873 · see citing works

Analysis of nanoparticle delivery to tumours

Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · see citing works

Liposomal drug delivery systems: From concept to clinical applications

Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · see citing works

Cellular uptake of nanoparticles: Journey inside the cell

Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859 · see citing works

Liposomes as nanomedical devices

Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,305 · see citing works

Progress and challenges towards targeted delivery of cancer therapeutics

Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220 · see citing works

Lipid NanoparticlesFrom Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221 · see citing works

Liposomal Formulations in Clinical Use: An Updated Review

Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,174 · see citing works

Controlled drug delivery vehicles for cancer treatment and their performance

Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167 · see citing works

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164 · see citing works

Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications

WICKI, A. N., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,912 · see citing works

The blood–brain barrier: Structure, regulation and drug delivery

Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906 · see citing works

Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies

Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,741 · see citing works

Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies

Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702 · see citing works

Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery

Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,674 · see citing works

New developments in liposomal drug delivery

Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600 · see citing works

Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors

Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,597 · see citing works

Liposomes: Structure, composition, types, and clinical applications

Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561 · see citing works

The evolution of commercial drug delivery technologies

Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361 · see citing works

Diverse Applications of Nanomedicine

Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350 · see citing works

A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives

Liu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334 · see citing works

Nanoparticles in the clinic

Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321 · see citing works

To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288 · see citing works

The Role of Ligands in the Chemical Synthesis and Applications of Inorganic Nanoparticles

Heuer‐Jungemann, A., Feliu, N., Bakaimi, I., Al‐Hamaly, M. A., Alkilany, A. M., Chakraborty, I., Masood, A., Casula, M. F., Κωστοπούλου, Α., Oh, E., et al. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00733 · Cited by 1,287 · see citing works

Smart cancer nanomedicine

van der Meel, R., Sulheim, E., Shi, Y., Kiessling, F. M., Mulder, W. J. M., & Lammers, T. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0567-y · Cited by 1,251 · see citing works

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,246 · see citing works

Extracellular vesicles as drug delivery systems: Why and how?

Elsharkasy, O. M., Nordin, J. Z., Hagey, D. W., de Jong, O. G., Schiffelers, R. M., Andaloussi, S. E., & Vader, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.004 · Cited by 1,217 · see citing works

The role of lipid components in lipid nanoparticles for vaccines and gene therapy

Gregersen, C. H., Kulkarni, J. A., Witzigmann, D., Lind, M. L., Petersson, K., & Simonsen, J. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114416 · Cited by 1,215 · see citing works

Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine

de Almeida, M. S., Sušnik, E., Drašler, B., Taladriz‐Blanco, P., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01127d · Cited by 1,108 · see citing works

Therapeutic Nanoparticles and Their Targeted Delivery Applications

Yetisgin, A. A., Çetinel, S., Zuvin, M., Koşar, A., & Kutlu, Ö. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,103 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

The Smart Drug Delivery System and Its Clinical Potential

Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066 · see citing works

Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization

Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,063 · see citing works

Therapeutic efficacy of nanoparticles and routes of administration

Chenthamara, D., Sadhasivam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,073 · see citing works

Targeting drugs to tumours using cell membrane-coated nanoparticles

Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980 · see citing works

Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances

Narayan, R., Nayak, U. Y., Raichur, A. M., & Garg, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030118 · Cited by 949 · see citing works

Bovine milk-derived exosomes for drug delivery

Munagala, R., Aqil, F., Jeyabalan, J., & Gupta, R. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.020 · Cited by 936 · see citing works

Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems

Yusuf, A., Almotairy, A. R. Z., Henidi, H. A., Alshehri, O. Y., & Aldughaim, M. S. (2023) · Polymers · doi:10.3390/polym15071596 · Cited by 978 · see citing works

Liposome composition in drug delivery design, synthesis, characterization, and clinical application

Large, D. E., Abdelmessih, R. G., Fink, E. A., & Auguste, D. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113851 · Cited by 886 · see citing works

Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine

Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864 · see citing works

Advances in Biomaterials for Drug Delivery

Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 869 · see citing works

Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment

Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 844 · see citing works

EPR: Evidence and fallacy

Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834 · see citing works

Innovative approaches for cancer treatment: current perspectives and new challenges

Pucci, C., Martinelli, C., & Ciofani, G. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.961 · Cited by 832 · see citing works

Recent progress in drug delivery

Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818 · see citing works

Clinical Translation of Nanomedicine

Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 795 · see citing works

Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers

Fang, J., Islam, W., & Maeda, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.005 · Cited by 757 · see citing works

Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744 · see citing works

Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems

Yoo, J., Park, C., Yi, G., Lee, D., & Koo, H. (2019) · Cancers · doi:10.3390/cancers11050640 · Cited by 730 · see citing works

Controlled drug delivery systems: Past forward and future back

Park, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.054 · Cited by 721 · see citing works

Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development

Mehta, M., Bui, T. A., Yang, X., Aksoy, Y. A., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 740 · see citing works

The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery

Cheng, X., & Lee, R. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.022 · Cited by 703 · see citing works

Supramolecular self-assemblies as functional nanomaterials

Busseron, E., Ruff, Y., Moulin, É., & Giuseppone, N. (2013) · Nanoscale · doi:10.1039/c3nr02176a · Cited by 699 · see citing works

Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals

Kozma, G. T., Shimizu, T., Ishida, T., & Szebeni, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.024 · Cited by 696 · see citing works

Cancer nanomedicine: from targeted delivery to combination therapy

Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693 · see citing works

Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs

Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 707 · see citing works

Current hurdles to the translation of nanomedicines from bench to the clinic

Đorđević, S., Gonzalez, M. M., Conejos‐Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi‐Fainaro, R., Florindo, H. F., & Vicent, M. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01024-2 · Cited by 715 · see citing works

Supramolecular chemotherapy based on host–guest molecular recognition: a novel strategy in the battle against cancer with a bright future

Zhou, J., Yu, G., & Huang, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00898d · Cited by 678 · see citing works

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment

Yang, M., Li, J., Gu, P., & Fan, X. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.010 · Cited by 680 · see citing works

Form Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine

Kinnear, C., Moore, T. L., Rodríguez‐Lorenzo, L., Rothen‐Rutishauser, B., & Petri‐Fink, A. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00194 · Cited by 673 · see citing works

Adapting liposomes for oral drug delivery

He, H., Lu, Y., Qi, J., Zhu, Q., Chen, Z., & Wu, W. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.06.005 · Cited by 663 · see citing works

Current Trends in The Use of Liposomes for Tumor Targeting

Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 663 · see citing works

Transport and interactions of nanoparticles in the kidneys

Du, B., Yu, M., & Zheng, J. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0038-3 · Cited by 651 · see citing works

Nanoparticles of Metal‐Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine

Simón‐Yarza, T., Mielcarek, A., Couvreur, P., & Serre, C. (2018) · Advanced Materials · doi:10.1002/adma.201707365 · Cited by 653 · see citing works

Size-Dependent In Vivo Transport of Nanoparticles: Implications for Delivery, Targeting, and Clearance

Xu, M., Qi, Y., Liu, G. H., Song, Y., Jiang, X., & Du, B. (2023) · ACS Nano · doi:10.1021/acsnano.3c05853 · Cited by 647 · see citing works

The role of micelle size in tumor accumulation, penetration, and treatment

Wang, J., Mao, W., Lock, L. L., Tang, J., Sui, M., Sun, W., Cui, H., Xu, D., & Shen, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b02017 · Cited by 635 · see citing works

Lipids and Lipid Derivatives for RNA Delivery

Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 638 · see citing works

Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment

Subhan, M. A., Yalamarty, S. S. K., Filipczak, N., Parveen, F., & Torchilin, V. P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060571 · Cited by 623 · see citing works

Managing diabetes with nanomedicine: challenges and opportunities

Omid Veiseh, A., Tang, B. C., Whitehead, K. A., Anderson, D. G., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4477 · Cited by 618 · see citing works

Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source

Meng, W., He, C., Hao, Y., Wang, L., Li, L., & Zhu, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748758 · Cited by 618 · see citing works

Nanocarriers for cancer-targeted drug delivery

Kumari, P., Ghosh, B., & Biswas, S. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1051049 · Cited by 612 · see citing works

Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches

Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606 · see citing works

Liposomal Drug Delivery Systems and Anticancer Drugs

Olusanya, T. O. B., Haj-Ahmad, R., Ibegbu, M. D., Smith, J. R., & Elkordy, A. (2018) · Molecules · doi:10.3390/molecules23040907 · Cited by 605 · see citing works

Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs

Bolla, G., Sarma, B., & Nangia, A. K. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00987 · Cited by 603 · see citing works

Recent advancements in liposome technology

Filipczak, N., Pan, J., Yalamarty, S. S. K., & Torchilin, V. P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.022 · Cited by 604 · see citing works

Hyaluronic acid for anticancer drug and nucleic acid delivery

Dosio, F., Arpicco, S., Stella, B., & Fattal, E. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.011 · Cited by 596 · see citing works

Nanopharmaceuticals (part 1): products on the market

Weissig, V., Pettinger, T. K., & Murdock, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s46900 · Cited by 591 · see citing works

Nanooncology: The future of cancer diagnosis and therapy

Thakor, A. S., & Gambhir, S. S. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21199 · Cited by 591 · see citing works

Stimuli‐responsive liposomes for drug delivery

Lee, Y. R., & Thompson, D. H. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1450 · Cited by 586 · see citing works

Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery

Ge, X., Wei, M., He, S., & Yuan, W. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020055 · Cited by 579 · see citing works

Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors

Gagliardi, A., Giuliano, E., Eeda, V., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 592 · see citing works

Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies

Chen, B., Cheng, T., & Roffler, S. R. (2021) · ACS Nano · doi:10.1021/acsnano.1c05922 · Cited by 573 · see citing works

Antibiofouling polymer interfaces: poly(ethylene glycol) and other promising candidates

Lowe, S. E., O’brien-simpson, N. M., & Connal, L. A. (2014) · Polymer Chemistry · doi:10.1039/c4py01356e · Cited by 557 · see citing works

Lipid Nanoparticles for Drug Delivery

Xu, L., Wang, X., Liu, Y., Yang, G., Falconer, R. J., & Zhao, C. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100109 · Cited by 568 · see citing works

Nanomedicines: addressing the scientific and regulatory gap

Tinkle, S. S., McNeil, S. E., Mühlebach, S., Bawa, R., Borchard, G., Barenholz, Y., Tamarkin, L., & Desai, N. P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12403 · Cited by 552 · see citing works

Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics

Vangijzegem, T., Stanicki, D., & Laurent, S. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1554647 · Cited by 553 · see citing works

The Limitless Future of RNA Therapeutics

Damase, T. R., Sukhovershin, R. A., Boada, C., Taraballi, F., Pettigrew, R. I., & Cooke, J. P. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.628137 · Cited by 549 · see citing works

Facing the Truth about Nanotechnology in Drug Delivery

Park, K. (2013) · ACS Nano · doi:10.1021/nn404501g · Cited by 545 · see citing works

Stimuli-Responsive Nanomaterials for Biomedical Applications

Blum, A. P., Kammeyer, J. K., Rush, A. M., Callmann, C. E., Hahn, M. E., & Gianneschi, N. C. (2014) · Journal of the American Chemical Society · doi:10.1021/ja510147n · Cited by 544 · see citing works

Ligand-targeted liposome design: challenges and fundamental considerations

Noble, G. T., Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgiçer, B. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.09.007 · Cited by 546 · see citing works

Cancer nanomedicines: So many papers and so few drugs!

Venditto, V. J., & Szoka, F. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.038 · Cited by 538 · see citing works

Safety of Nanoparticles in Medicine

Wolfram, J., Zhu, M., Yang, Y. P., Shen, J., Gentile, E., Paolino, D., Fresta, M., Nie, G., Chen, C., Shen, H., et al. (2015) · Current Drug Targets · doi:10.2174/1389450115666140804124808 · Cited by 535 · see citing works

Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery

Eloy, J. O., de Souza, M. C., Petrilli, R., Barcellos, J. P. A., Lee, R. J., & Marchetti, J. M. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.09.029 · Cited by 535 · see citing works

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review

Viegas, C., Patrício, A. B., Prata, J., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 565 · see citing works

Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines

Thi, T. T. H., Suys, E. J. A., Lee, J. S., Nguyen, D. H., Park, K. D., & Truong, N. P. (2021) · Vaccines · doi:10.3390/vaccines9040359 · Cited by 538 · see citing works

PEGylated liposomes: immunological responses

Sayed, M. M. E., Lila, A. S. A., Shimizu, T., Alaaeldin, E., Hussein, A. K., Sarhan, H. A., Szebeni, J., & Ishida, T. (2019) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2019.1627174 · Cited by 536 · see citing works

State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines

Dawidczyk, C. M., Kim, C., Park, J. H., Russell, L. M., Lee, K. H., Pomper, M. G., & Searson, P. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.036 · Cited by 526 · see citing works

An overview of clinical and commercial impact of drug delivery systems

Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 523 · see citing works

Doxil® — The First FDA-Approved Nano-Drug: From an Idea to a Product

Peer, D. (2012) · doi:10.1201/b11620-14

Doxil®: The First FDA-Approved Nanodrug—From an Idea to a Product (January 2015 Update)

Bawa, R., Audette, G. F., & Rubinstein, I. (2016) · doi:10.1201/b19915-39 · Cited by 2 · see citing works

Preparation of Doxorubicin Liposomes by Remote Loading Method

Chen, J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2954-3_8 · Cited by 10 · see citing works

Journey of Nano-Drug Delivery Systems from Lab to Clinics

Purkait, M. K., Sontakke, A. D., & Anweshan, A. (2023) · CRC Press eBooks · doi:10.1201/9781003358114-12

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.

Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382 · see citing works